Regis Healthcare Limited (ASX:REG)
Australia · Delayed Price · Currency is AUD 6.97
+0.02 (0.29%)
Mar 2, 2026, 4:11 PM AEST
Regis Healthcare Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 1,265 | 1,161 | 1,014 | 780.61 | 725.33 | 701.37 | |
Revenue Growth (YoY) | 15.18% | 14.52% | 29.90% | 7.62% | 3.42% | 3.47% |
Cost of Revenue | 1,062 | 961.52 | 838.8 | 647.27 | 609.61 | 574.43 |
Gross Profit | 202.45 | 199.77 | 175.25 | 133.34 | 115.72 | 126.93 |
Selling, General & Admin | 87.83 | 89.93 | 88.06 | 76.77 | 66.14 | 62.93 |
Amortization of Goodwill & Intangibles | - | - | 81.38 | 81.38 | 61.04 | - |
Operating Expenses | 139.96 | 139.74 | 216.14 | 203.24 | 169.25 | 106.82 |
Operating Income | 62.5 | 60.03 | -40.89 | -69.9 | -53.53 | 20.11 |
Interest Expense | -138.45 | -116.43 | -88.61 | -70.85 | -66.68 | -70.07 |
Interest & Investment Income | 139.16 | 118.48 | 85.5 | 63.58 | 62.45 | 64.4 |
Other Non Operating Income (Expenses) | -2.76 | -3.07 | -2.87 | -2.75 | -3.7 | -3.93 |
EBT Excluding Unusual Items | 60.44 | 59 | -46.86 | -79.92 | -61.46 | 10.52 |
Merger & Restructuring Charges | -12.31 | - | - | - | - | - |
Gain (Loss) on Sale of Assets | 3.35 | 3.43 | 5.06 | 11.65 | - | 2.82 |
Asset Writedown | 4.5 | 4.5 | - | 0.64 | 3.02 | 11.66 |
Other Unusual Items | 2.22 | 4.5 | 13.69 | 27.25 | 3.25 | 4.16 |
Pretax Income | 58.19 | 71.44 | -28.1 | -40.38 | -55.19 | 29.15 |
Income Tax Expense | 20.16 | 22.49 | -6.69 | -11.93 | -16.39 | 9.2 |
Net Income | 38.03 | 48.95 | -21.42 | -28.45 | -38.8 | 19.95 |
Net Income to Common | 38.03 | 48.95 | -21.42 | -28.45 | -38.8 | 19.95 |
Net Income Growth | 152.08% | - | - | - | - | - |
Shares Outstanding (Basic) | 302 | 301 | 301 | 301 | 301 | 301 |
Shares Outstanding (Diluted) | 303 | 304 | 301 | 301 | 301 | 301 |
Shares Change (YoY) | 0.29% | 0.93% | 0.05% | 0.02% | -0.01% | 0.02% |
EPS (Basic) | 0.13 | 0.16 | -0.07 | -0.09 | -0.13 | 0.07 |
EPS (Diluted) | 0.13 | 0.16 | -0.07 | -0.09 | -0.13 | 0.07 |
EPS Growth | 151.28% | - | - | - | - | - |
Free Cash Flow | 233.44 | 219.64 | 186.57 | 53.73 | 67.6 | 87.75 |
Free Cash Flow Per Share | 0.77 | 0.72 | 0.62 | 0.18 | 0.23 | 0.29 |
Dividend Per Share | 0.171 | 0.162 | 0.129 | 0.095 | 0.058 | 0.066 |
Dividend Growth | 16.29% | 25.54% | 36.29% | 62.33% | -11.92% | 64.92% |
Gross Margin | 16.01% | 17.20% | 17.28% | 17.08% | 15.95% | 18.10% |
Operating Margin | 4.94% | 5.17% | -4.03% | -8.95% | -7.38% | 2.87% |
Profit Margin | 3.01% | 4.21% | -2.11% | -3.65% | -5.35% | 2.84% |
Free Cash Flow Margin | 18.46% | 18.91% | 18.40% | 6.88% | 9.32% | 12.51% |
EBITDA | 113.17 | 108.56 | 86.22 | 55.19 | 48.59 | 63.01 |
EBITDA Margin | 8.95% | 9.35% | 8.50% | 7.07% | 6.70% | 8.98% |
D&A For EBITDA | 50.67 | 48.53 | 127.11 | 125.09 | 102.12 | 42.9 |
EBIT | 62.5 | 60.03 | -40.89 | -69.9 | -53.53 | 20.11 |
EBIT Margin | 4.94% | 5.17% | -4.03% | -8.95% | -7.38% | 2.87% |
Effective Tax Rate | 34.64% | 31.48% | - | - | - | 31.56% |
Revenue as Reported | 1,414 | 1,292 | 1,118 | 897.61 | 796.95 | 784.4 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.